In a mouse model with ERα-deficiency in hepatocytes, the capacity of estrogens to decrease liver steatosis has been demonstrated to be lost, suggesting that estrogens act directly in the liver to lower triglycerides through ERα [130]. The gene discussed is ESR1; the disease is Hepatic steatosis.